Market Place
Sourcing Support
All News #Library
Rare Diseases
Acadia Pushes For Re-Review Of CHMP`s Daybue Snub
03 Mar 2026 //
FIERCE PHARMA
Acadia Expects EU Snub In Rett Syndrome
03 Feb 2026 //
BUSINESSWIRE
Acadia Pharma Gets FDA Nod For DAYBUE STIX In Rett Syndrome
12 Dec 2025 //
BUSINESSWIRE
Acadia Ph 3 Carbetocin Trial In PWS Hyperphagia Misses Endpoint
24 Sep 2025 //
BUSINESSWIRE
Acadia Pharmaceuticals to Host R&D Day in NYC on June 25, 2025
05 Jun 2025 //
BUSINESSWIRE
Acadia Pharmaceuticals Appoints Allyson as Senior Vice President
27 May 2025 //
BUSINESSWIRE
Long-term safety of Daybue (trofinetide) in Rett Syndrome patient
05 Mar 2025 //
BUSINESSWIRE
Acadia Pharma Closes Sale of Pediatric Disease Priority Review
11 Dec 2024 //
BUSINESSWIRE
Acadia Sells Rare Pediatric Disease Priority Review Voucher for $150M
05 Nov 2024 //
BUSINESSWIRE
Acadia adds awareness-raising docuseries to Rett syndrome site
15 May 2024 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.